Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer

Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer

Radiogenomic heterogeneity features in <sup>18</sup>F-fluorodeoxyglucose positron emission tomography (<sup>18</sup>F-FDG PET) have become popular in non-small cell lung cancer (NSCLC) research. However, the reliabilities of genomic heterogeneity features and of PET-based gly...

Full description

Bibliographic Details
Main Authors:	Yu-Hung Chen, Kun-Han Lue, Chih-Bin Lin, Kuang-Chi Chen, Sheng-Chieh Chan, Sung-Chao Chu, Bee-Song Chang, Yen-Chang Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	tumor heterogeneity whole exome sequencing <sup>18</sup>F-FDG PET molecular imaging lung cancer
Online Access:	https://www.mdpi.com/1422-0067/24/4/3988

Similar Items

Prognostic Value of Combing Primary Tumor and Nodal Glycolytic–Volumetric Parameters of <sup>18</sup>F-FDG PET in Patients with Non-Small Cell Lung Cancer and Regional Lymph Node Metastasis
by: Yu-Hung Chen, et al.
Published: (2021-06-01)

Advances in Molecular Imaging in Infective Endocarditis
by: Katarzyna Holcman, et al.
Published: (2023-02-01)

Pulmonary and Liver Toxocariasis Mimicking Metastatic Tumors in a Patient with Colon Cancer
by: Miju Cheon, et al.
Published: (2023-12-01)

Intense FDG Uptake in the Common Bile Duct Post-ERCP Mimics Acute Infectious Cholangitis
by: Neel P. Mistry, et al.
Published: (2022-12-01)

The Additional Value of <sup>18</sup>F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020
by: Natale Quartuccio, et al.
Published: (2020-05-01)

Image Quality and Quantitative PET Parameters of Low-Dose [<sup>18</sup>F]FDG PET in a Long Axial Field-of-View PET/CT Scanner
by: Eduardo Calderón, et al.
Published: (2023-10-01)

Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [<sup>18</sup>F]FDG PET/CT Imaging and Clinical Features
by: Ine Dirks, et al.
Published: (2023-08-01)

The Relationship between Brown Adipose Tissue Activity and Neoplastic Status: an <sup>18</sup>F-FDG PET/CT Study in the Tropics
by: Huang Yung-Cheng, et al.
Published: (2011-12-01)

The Association of Preoperative PET-CT and Survival in Patients with Resectable Cervical Cancer
by: Chih-Hsiung Su, et al.
Published: (2022-12-01)

Usefulness of <sup>18</sup>F-FDG PET-CT in the Management of Febrile Neutropenia: A Retrospective Cohort from a Tertiary University Hospital and a Systematic Review
by: Andrea Gutiérrez-Villanueva, et al.
Published: (2024-01-01)

Heterogeneity of Glycolytic Phenotype Determined by <sup>18</sup>F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer
by: Sara Pellegrino, et al.
Published: (2023-07-01)

Clinical Utility of <sup>18</sup>F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis
by: Emmanouil Alevroudis, et al.
Published: (2021-04-01)

Prognostic Value of Baseline Radiomic Features of <sup>18</sup>F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
by: Kun-Han Lue, et al.
Published: (2020-12-01)

Choline PET/CT in Multiple Myeloma
by: Charles Mesguich, et al.
Published: (2020-05-01)

A Case Report of Early-Onset Alzheimer’s Disease Using <sup>18</sup>F-FDG PET and <sup>18</sup>F-FBB PET
by: Jang Yoo, et al.
Published: (2023-05-01)

PET-Based Imaging with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
by: William Y. Raynor, et al.
Published: (2021-11-01)

The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review
by: Luca Urso, et al.
Published: (2023-04-01)

Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via <sup>18</sup>F-Sodium Fluoride PET/CT Imaging
by: Carmela Nappi, et al.
Published: (2024-01-01)

If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[<sup>18</sup>F]FDG Metabolism
by: Eva-Maria Klebermass, et al.
Published: (2021-09-01)

Relationship between Standard Uptake Values of Positron Emission Tomography/Computed Tomography and Salivary Metabolites in Oral Cancer: A Pilot Study
by: Shigeo Ishikawa, et al.
Published: (2020-12-01)

Is Imaging Bacteria with PET a Realistic Option or an Illusion?
by: Shashi B. Singh, et al.
Published: (2023-03-01)

The Prognostic Value of <sup>18</sup>F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review
by: Silvia Taralli, et al.
Published: (2021-12-01)

Place of the <sup>18</sup>F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO)
by: Simon Letertre, et al.
Published: (2021-08-01)

Prognostic Value of Sarcopenia and Metabolic Parameters of <sup>18</sup>F-FDG-PET/CT in Patients with Advanced Gastroesophageal Cancer
by: Ricarda Hinzpeter, et al.
Published: (2023-02-01)

Lyme Neuroborreliosis in a Patient with Breast Cancer: MRI and PET/CT Findings
by: Mathilde Ørbæk, et al.
Published: (2020-01-01)

Can the Efficacy of [<sup>18</sup>F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
by: Hazel O’Neill, et al.
Published: (2019-01-01)

Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
by: Ricarda Hinzpeter, et al.
Published: (2022-10-01)

Glucose Loading Enhances the Value of <sup>18</sup>F-FDG PET/CT for the Characterization and Delineation of Cerebral Gliomas
by: Dongwoo Kim, et al.
Published: (2020-07-01)

Different Uptake of <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG in Lymphadenopathy Caused by Angioimmunoblastic T-Cell Lymphoma in a Patient with Colon Cancer
by: Meiqi Wu, et al.
Published: (2022-09-01)

Attempts to Target <em>Staphylococcus aureus</em> Induced Osteomyelitis Bone Lesions in a Juvenile Pig Model by Using Radiotracers
by: Pia Afzelius, et al.
Published: (2020-09-01)

Prognostic Role of Pre-Treatment [<sup>18</sup>F]FDG PET/CT in Patients with Anaplastic Thyroid Cancer
by: Hyun Jeong Kim, et al.
Published: (2021-08-01)

<sup>18</sup>F-FDG PET Is Not Inferior to <sup>68</sup>Ga-PSMA PET for Detecting Biochemical Recurrent Prostate Cancer with a High Gleason Score: A Head-to-Head Comparison Study
by: Lian Xu, et al.
Published: (2023-12-01)

Effect of Denoising and Deblurring <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Images on a Deep Learning Model’s Classification Performance for Alzheimer’s Disease
by: Min-Hee Lee, et al.
Published: (2022-03-01)

PET/CT May Assist in Avoiding Pointless Thyroidectomy in Indeterminate Thyroid Nodules: A Narrative Review
by: Gaby Abou Karam, et al.
Published: (2023-02-01)

Comparison of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI in Spindle Cell Rhabdomyosarcoma
by: Zhihui Shen, et al.
Published: (2023-09-01)

A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)
by: Alice Laffi, et al.
Published: (2021-12-01)

<sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer
by: A. V. Leontyev, et al.
Published: (2022-12-01)

Correlation between Histopathological Prognostic Tumor Characteristics and [<sup>18</sup>F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer
by: Jorianne Boers, et al.
Published: (2024-02-01)

Comparison of the Diagnostic Value of MRI and Whole Body <sup>18</sup>F-FDG PET/CT in Diagnosis of Spondylodiscitis
by: Corinna Altini, et al.
Published: (2020-05-01)

Mesonephric Adenocarcinoma of the Uterine Fundus Exhibiting High <sup>18</sup>F-FDG Uptake
by: Hyung Kyung Kim, et al.
Published: (2020-09-01)